A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT02518139 · COMPLETED

Trial details

NCT number: NCT02518139
Sponsor: Mylan Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2015-09-01
Primary completion: 2017-06-01
Enrollment: 1060

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.